Neeha Zaidi
Works at
Sources: reporter.nih.gov
Grants and prizes
R37, Mutant KRAS targeted vaccines for the interception of pancreatic cancer development, R37CA292056, 2024–2029, Aug 6, 2026
Sources: reporter.nih.gov
Sources: reporter.nih.gov
R37, Mutant KRAS targeted vaccines for the interception of pancreatic cancer development, R37CA292056, 2024–2029, Aug 6, 2026
Sources: reporter.nih.gov